It is suspected that radiation retinopathy is more likely to develop in an eye with preexisting diabetic retinopathy than in a normal eye. However, there is only one report of this occurring, at a radiation dose of 4500 rads. We present a woman with minimal diabetic retinopathy who had breast carcinoma which was treated with chemotherapy but metastasised to the choroid. Within nine months of external beam radiation (3000 rads in fractions of 200 rads) a fulminant retinopathy evolved in that eye, while the non-radiated eye showed no change. The histopathology of radiation and diabetic retinopathy and causes for possible synergism are discussed. As this case report shows, radiation oncologists and ophthalmologists need to be aware of the risk that patients with minimal diabetic retinopathy who have undergone chemotherapy may suffer a dramatic visual loss from radiation therapy despite a radiation dose which is considered adequate, safe, and properly fractionated.
Radiation damage in tissues may result from direct parenchymal damage, usually in a rapidly dividing cell system such as intestinal epithelium, or from delayed effects caused by damage to vascular and interstitial support structures.' In the eye, radiation retinopathy is a disease resulting from damage to retinal blood vessels.2'-Gass states that, clinically and angiographically, radiation retinopathy is virtually identical to diabetic retinopathy. 6 Several authors have noted that patients with diabetes or hypertension may be particularly susceptible to radiation induced vascular damage.'578 However, we could find only one case report of this occurring. In this case a moderate radiation dose (4500 rads was given to the fovea by cobalt-60 plaque irradiation) caused radiation retinopathy in a diabetic patient.5 Chemotherapy is also thought to augment the damaging effects of radiation to the posterior segment of the eye even if it is not concomitant with radiation.'I57
In this paper we describe a case of a woman in which the combined effects of pre-existing minimal diabetic retinopathy, previous chemotherapy, and radiation therapy led to a fulminant retinopathy despite a dose of external beam radiation which was considered adequate, safe, and properly fractionated. (Figs 1 and 2 ). In the right fundus a creamy white choroidal lesion between 3 and 5 o'clock in the far inferonasal periphery with secondary shallow retinal detachment was noted, consistent with metastatic carcinoma (Fig 3) . A fluorescein angiogram showed very early leakage from this mass lesion which continued throughout the course of the study. A diagnosis of choroidal metastasis from primary breast carcinoma was made. With the 4 MeV linear accelerator the lesion was treated with a total of 3000 rads over three weeks, in fractions of 200 rads.
One month after treatment the secondary retinal detachment had disappeared. The visual acuity and the appearance of mild background diabetic retinopathywere unchanged. Six months after radiotherapy the visual acuity remained unchanged but the retinopathy had markedly increased in the right eye. Cotton-wool spots were now present as well as increased haemorrhages and oedema. Seven months after radiation visual acuity in the right eye had decreased to 20 (Fig 8) . 6 Further progression ofthe right eye with significant intraretinal haemorrhages and cotton-wool spots nine months after radiation therapy (red-free photograph). Figure 7 Thefluorescein angiogram ofthe right eye shows Figure 8 The left eye remains unchanged, exhibiting marked capillary non-perfusion nine months after radiation minimal background diabetic retinopathy changes with a few therapy (30.6 seconds after dye injection).
microaneurysms and dot haemorrhages (red-free photograph 15 The severity of the retinopathy is thought to be related to total radiation dosage and to the fractionation of that dosage.' 3712 The total time of the treatment is also of significance.'
There is general agreement that 3000 rads with a standard fractionation of 1000 rads per week in five fractions (200 rads per treatment session), is a safe total dose of external beam radiation, though there are reports in which radiation retinopathy occurred at lower doses.258 However, these dosages were reconstructed, and a low energy 220 KV machine was used which has a higher incidence of complications than contemporary radiotherapeutic emitters.' The time course of retinopathic changes is variable, with an onset between six months and three years after radiotherapy, but earlier and later changes have been noted.5 Higher doses of radiation are not known to be associated with a shortened latency period, but the use of adjunct chemotherapy may be.35 I' 16 Conditions thought to enhance the development of radiation vasculopathy include vascular diseases like diabetes, hypertension, collagen vascular disease, or chemotherapy. ' 5I7 However, we found only one previous report in the literature in which a moderate dose of radiation (4500 rads was given to the fovea by cobalt-60 plaque irradiation) caused radiation retinopathy in a diabetic patient.5 In this study the authors noted that eyes which progressed to total blindness from radiation damage had received chemotherapy more frequently than eyes with less damage. The 
